These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 29630442)

  • 1. High Thyroid Cancer Mortality Rate in Japan: A Result of Nonaggressive Treatment Strategy, or Just an Aging Population?
    Magner JA
    Thyroid; 2018 Jun; 28(6):818-819. PubMed ID: 29630442
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: "High Thyroid Cancer Mortality Rate in Japan: A Result of Nonaggressive Treatment Strategy, or Just an Aging Population?" By Magner (Thyroid 2018;28:818-819).
    Davies L; Sugino K; Sugitani I; Tomoda C
    Thyroid; 2018 Jun; 28(6):820-822. PubMed ID: 29644937
    [No Abstract]   [Full Text] [Related]  

  • 3. Should papillary thyroid carcinoma be observed?: a word of caution.
    Sturgis EM; Sherman SI
    Arch Otolaryngol Head Neck Surg; 2010 May; 136(5):444-6. PubMed ID: 20479372
    [No Abstract]   [Full Text] [Related]  

  • 4. Current thyroid cancer trends in the United States.
    Davies L; Welch HG
    JAMA Otolaryngol Head Neck Surg; 2014 Apr; 140(4):317-22. PubMed ID: 24557566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of imaging tests after primary treatment of thyroid cancer in the United States: population based retrospective cohort study evaluating death and recurrence.
    Banerjee M; Wiebel JL; Guo C; Gay B; Haymart MR
    BMJ; 2016 Jul; 354():i3839. PubMed ID: 27443325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing newly diagnosed thyroid cancer.
    Sawka AM; Brierley JD; Ezzat S; Goldstein DP
    CMAJ; 2014 Mar; 186(4):269-75. PubMed ID: 24101616
    [No Abstract]   [Full Text] [Related]  

  • 7. Thyroid Cancer: 20-Year Comparative Mortality and Survival Analysis of Six Thyroid Cancer Histologic Subtypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration (SEER*Stat 8.3.2) A Systematic Review of 145,457 Cases for Diagnosis Years 1993-2013.
    Milano AF
    J Insur Med; 2018 Jan; 47(3):143-158. PubMed ID: 30192723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing incidence of thyroid cancer in the United States, 1973-2002.
    Davies L; Welch HG
    JAMA; 2006 May; 295(18):2164-7. PubMed ID: 16684987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical observation on thyroid cancer].
    Sato F; Saito H; Mizukoshi O
    Nihon Jibiinkoka Gakkai Kaiho; 1971 Oct; 74(10):1482-95. PubMed ID: 5169515
    [No Abstract]   [Full Text] [Related]  

  • 10. Thyroid cancer in the USA: current trends and outstanding questions.
    Davies L; Hoang JK
    Lancet Diabetes Endocrinol; 2021 Jan; 9(1):11-12. PubMed ID: 33220765
    [No Abstract]   [Full Text] [Related]  

  • 11. Paradoxes in thyroid carcinoma treatment: analysis of the SEER database 2010-2013.
    Zhou P; Tian S; Li J; Zhao Y; Liu W; Zhang Y; Hu Z
    Oncotarget; 2017 Jan; 8(1):345-353. PubMed ID: 27861148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of secondary primary malignancy in early stage differentiated thyroid cancer: a US population-based study.
    Uprety D; Khanal A; Arjyal L; Bista A; Basnet B; Kandel P; Gogireddy TR; Adhikari J
    Acta Oncol; 2016 Nov; 55(11):1375-1377. PubMed ID: 27579851
    [No Abstract]   [Full Text] [Related]  

  • 13. Patients with follicular and Hurthle cell microcarcinomas have compromised survival: a population level study of 22,738 patients.
    Kuo EJ; Roman SA; Sosa JA
    Surgery; 2013 Dec; 154(6):1246-53; discussion 1253-4. PubMed ID: 23993409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revisiting overdiagnosis and fatality in thyroid cancer.
    Vollmer RT
    Am J Clin Pathol; 2014 Jan; 141(1):128-32. PubMed ID: 24343746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients.
    Kazaure HS; Roman SA; Sosa JA
    Ann Surg Oncol; 2012 Jun; 19(6):1874-80. PubMed ID: 22065195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hurthle cell carcinoma: a population-level analysis of 3311 patients.
    Goffredo P; Roman SA; Sosa JA
    Cancer; 2013 Feb; 119(3):504-11. PubMed ID: 22893587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid cancer epidemiology and prognostic variables.
    Sipos JA; Mazzaferri EL
    Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):395-404. PubMed ID: 20627675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing trends in mortality of thyroid cancer in Belgrade population.
    Bukvic B; Sipetic S; Kalezic N; Diklic A; Paunovic I; Kovacevic B; Knezevic A; Zivaljevic V
    J BUON; 2011; 16(2):337-40. PubMed ID: 21766507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Age on Response to Therapy and Mortality in Patients With Thyroid Cancer at High Risk of Recurrence.
    Shah S; Boucai L
    J Clin Endocrinol Metab; 2018 Feb; 103(2):689-697. PubMed ID: 29220531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancers of the Thyroid: Overview and Statistics in the United States and Oklahoma.
    Deen MH; Burke KM; Janitz A; Campbell J
    J Okla State Med Assoc; 2016; 109(7-8):333-338. PubMed ID: 27885302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.